1. Home
  2. PMTS vs CCCC Comparison

PMTS vs CCCC Comparison

Compare PMTS & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

HOLD

Current Price

$16.30

Market Cap

183.1M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.02

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMTS
CCCC
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.1M
240.3M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PMTS
CCCC
Price
$16.30
$2.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$32.00
$7.25
AVG Volume (30 Days)
58.6K
1.5M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.20
N/A
Revenue
$515,576,000.00
$30,108,000.00
Revenue This Year
$13.70
N/A
Revenue Next Year
$8.51
N/A
P/E Ratio
$13.51
N/A
Revenue Growth
12.48
N/A
52 Week Low
$11.64
$1.09
52 Week High
$35.19
$4.44

Technical Indicators

Market Signals
Indicator
PMTS
CCCC
Relative Strength Index (RSI) 53.37 33.81
Support Level $15.83 $2.50
Resistance Level $18.23 $2.69
Average True Range (ATR) 0.88 0.19
MACD 0.11 -0.07
Stochastic Oscillator 54.62 2.37

Price Performance

Historical Comparison
PMTS
CCCC

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: